Are we ready for targeted therapy combinations in HCC?

Einat Cinnamon; Eli Pikarsky

doi:10.1136/gutjnl-2019-319780

Are we ready for targeted therapy combinations in HCC?

Einat Cinnamon
, Eli Pikarsky^*

^*Corresponding author for this work

Department of Immunology and Cancer Research

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Original language	English
Pages (from-to)	613-614
Number of pages	2
Journal	Gut
Volume	69
Issue number	4
DOIs	https://doi.org/10.1136/gutjnl-2019-319780
State	Published - 1 Apr 2020

Bibliographical note

Funding Information:
together written the paper. Funding This study was funded by the Israel Science Foundation and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

hepatocellular carcinoma

Access to Document

10.1136/gutjnl-2019-319780

Cite this

@article{de1b59479aa641a0a2db955d05bf386c,

title = "Are we ready for targeted therapy combinations in HCC?",

keywords = "hepatocellular carcinoma",

author = "Einat Cinnamon and Eli Pikarsky",

note = "Funding Information: together written the paper. Funding This study was funded by the Israel Science Foundation and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.",

year = "2020",

month = apr,

day = "1",

doi = "10.1136/gutjnl-2019-319780",

language = "אנגלית",

volume = "69",

pages = "613--614",

journal = "Gut",

issn = "0017-5749",